跳至主要内容
临床试验/NCT05942937
NCT05942937招募中不适用

National Prisons Hepatitis Education Project: Research Evaluation

Kirby Institute4 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2023年9月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
4
主要终点
The change in the proportion of prisoners treated for HCV before and after the education intervention.

研究概览

简要总结

The National Prisons Hepatitis Education Program (HepPEd Program) is a national, prison-based hepatitis C health literacy education program for healthcare providers, correctional officers, and people in prison. The HepPEd Program aims to improve the public health literacy of the prison sector regarding hepatitis C in prisons.

The HepPEd: Research Evaluation aims to evaluate the impact of the HepPEd Program on HCV testing and treatment uptake amongst people incarcerated in Australian prisons, as well as changes in knowledge, attitudes, and capabilities of healthcare providers, correctional officers, and people in prison. The study is a controlled before and after study being conducted in 3-6 correctional centres in Australia.

详细描述

The National Prisons Hepatitis Education Program (HepPEd Program) is a national, prison-based hepatitis C health literacy education program for healthcare providers, correctional officers, and people in prison.

The broad goal of HepPEd: Research Evaluation is to measure the impact of a prison-specific hepatitis C (HCV) education program (the HepPEd Program) on enhancing HCV testing and treatment rates in Australian prisons. The HepPEd Program aims to improve HCV testing and treatment rates by enhancing the public health literacy of the prison sector regarding HCV in the prisons (that is the knowledge, attitudes and behaviours), and specifically targets the three key audience groups from the prison setting: healthcare providers, correctional officers, and people in prison.

The study will be conducted as a prison-level, controlled before-and-after trial with a primary objective of evaluating the impact of the HepPEd Program on HCV treatment uptake amongst people incarcerated in Australian prisons. Three to six Australian correctional centres will be selected to participate in the 9-month study. Each correctional centre will have a 3-month period of pre-intervention surveillance, involving monthly observation of HCV treatment uptake under existing operations. This will be followed by a three-month period of education delivery of the HepPEd Program (the 'education intervention'). The monthly surveillance data collection will continue during the intervention period. Finally, each correctional centre will have another 3-month period of post-intervention surveillance, again involving monthly surveillance of HCV treatment rates. Surveys will be conducted with members from each target audience group before and after the education intervention and dried blood spot testing will be conducted with members from the people in prison group to assess baseline HCV prevalence before the education intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Whole-of-prison education intervention

Experimental

The HepPEd Program will saturate the entire prison during a 3-month intervention phase.

干预措施: Education Intervention (The HepPEd Program) (Other)

结局指标

主要结局

The change in the proportion of prisoners treated for HCV before and after the education intervention.

时间窗: 9 months from baseline

This will be measured by calculating the change in HCV treatment rates before and after the education intervention.

次要结局

  • The health literacy (knowledge, attitudes, and capabilities) amongst target audience groups (healthcare providers, correctional officers, and people in prison) before and after the education intervention.(9 months from baseline)
  • The proportion of prisoners tested for HCV before and after the education intervention.(9 months from baseline)
  • The acceptability, utility, and impact of the HepPEd Program.(9 months from baseline)
  • The dose, reach, and fidelity of the HepPEd Program.(9 months from baseline)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验